Covance was acquired by Labcorp in 2015 and officially rebranded as Labcorp Drug Development in 2021. In 2023, the clinical development portion was spun off as an independent company named Fortrea . Key Services:

(often sold as Covance CP or Covance 50) is a brand name for the prescription drug Losartan . Primary Uses: Treats high blood pressure (hypertension).

Are you interested in through the company, or Overview of Covance Clinical Research and Drug Discovery

Volunteers can find active clinical trials through the official Labcorp site or ClinicalTrials.gov . 2. Covance (The Medication)

Operating central laboratories for specimen testing and medical device verification.

Managing phases I–IV of drug development for pharmaceutical and biotech firms.

Reduces the risk of in patients with an enlarged heart. Protects kidney function in patients with Type 2 diabetes.

This medication is unsafe during pregnancy and can cause serious harm to an unborn baby.